Waddell & Reed Financial’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-65,000
Closed -$12.4M 579
2018
Q3
$12.4M Sell
65,000
-10,000
-13% -$1.84M 0.03% 382
2018
Q2
$12.5M Buy
75,000
+5,000
+7% +$803K 0.03% 388
2018
Q1
$11.8M Sell
70,000
-8,000
-10% -$1.34M 0.03% 392
2017
Q4
$12.8M Sell
78,000
-307,304
-80% -$55.1M 0.03% 391
2017
Q3
$79M Sell
385,304
-458,649
-54% -$107M 0.18% 147
2017
Q2
$205M Sell
843,953
-88,143
-9% -$20.7M 0.45% 58
2017
Q1
$223M Buy
932,096
+73,987
+9% +$17.2M 0.47% 58
2016
Q4
$180M Sell
858,109
-2,501,848
-74% -$518M 0.39% 67
2016
Q3
$774M Buy
3,359,957
+139,980
+4% +$34.2M 1.6% 5
2016
Q2
$744M Buy
3,219,977
+18,285
+0.6% +$4.22M 1.57% 6
2016
Q1
$858M Sell
3,201,692
-910,587
-22% -$261M 1.61% 7
2015
Q4
$1.29B Sell
4,112,279
-245,124
-6% -$73M 2.08% 3
2015
Q3
$1.18B Sell
4,357,403
-29,214
-0.7% -$8.97M 1.95% 4
2015
Q2
$1.33B Sell
4,386,617
-379,838
-8% -$113M 1.9% 3
2015
Q1
$1.42B Buy
4,766,455
+1,354,120
+40% +$386M 1.97% 2
2014
Q4
$878M Buy
+3,412,335
New +$853M 1.22% 13

Other funds holding AGN

Waddell & Reed Financial's AGN Position: Q4 2018 in Review

Waddell & Reed Financial sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 65,000 shares — an estimated $12.4M sold.

Waddell & Reed Financial first reported a position in AGN in Q4 2014 and held it in 16 quarters. The position peaked at $1.42B in Q1 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Waddell & Reed Financial reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Waddell & Reed Financial sold 65,000 Allergan plc shares in Q4 2018, an estimated $12.4M.
  • Waddell & Reed Financial first reported a position in Allergan plc in Q4 2014 and held it in 16 quarters.
  • Waddell & Reed Financial's Allergan plc position peaked at $1.42B in Q1 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Waddell & Reed Financial's 13F filing for Q4 2018, filed 14 Feb 2019.